Neuronetics Reports Q1 2026 Earnings with Revenue Growth and Improved Efficiency
Neuronetics (STIM) reported Q1 2026 earnings with total revenue of $34.5 million, up 8%, driven by higher U.S. clinic revenue. The company saw a net loss of $10.8 million, a reduction from the previous year, and improved operating expenses by 6% due to efficiency gains.
Topics: clinic revenue earnings financial performance revenue SPRAVATO TMS volume